# The Efficacy and Safety of HAIC With FOLFOX vs Sorafenib for Patients Who Showed TACE-resistant: a Retrospective Study

> **NCT05121571** · NA · COMPLETED · sponsor: **Sun Yat-sen University** · enrollment: 114 (actual)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **PROCEDURE:** HAIC
- **DRUG:** Sorafenib

## Key facts

- **NCT ID:** NCT05121571
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04-21
- **Primary completion:** 2018-12-12
- **Final completion:** 2021-05-01
- **Target enrollment:** 114 (ACTUAL)
- **Last updated:** 2021-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05121571

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05121571, "The Efficacy and Safety of HAIC With FOLFOX vs Sorafenib for Patients Who Showed TACE-resistant: a Retrospective Study". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05121571. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*